Literature DB >> 28986808

Contrast-induced nephropathy-time for Western medicine and Chinese medicine to team up.

Svante Norgren1,2, Xue-Zhong Gong3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28986808     DOI： 10.1007/s11655-017-2905-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  15 in total

1.  Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis.

Authors:  Y Yamaguchi; S Kagota; K Nakamura; K Shinozuka; M Kunitomo
Journal:  Phytother Res       Date:  2000-12       Impact factor: 5.878

Review 2.  Computational systems biology.

Authors:  Hiroaki Kitano
Journal:  Nature       Date:  2002-11-14       Impact factor: 49.962

3.  Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science.

Authors:  Wen-Yue Jiang
Journal:  Trends Pharmacol Sci       Date:  2005-09-26       Impact factor: 14.819

4.  Efficacy of short-term cordyceps sinensis for prevention of contrast-induced nephropathy in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.

Authors:  Kai Zhao; Yu Lin; Yong-Jian Li; Sheng Gao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

5.  Protective Effects of Salvianolate on Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention: A Prospective Multicenter Randomized Controlled Trial.

Authors:  Jing Huang; Minjie Yuan; Jian Ma; Rong Liu; Zhifeng Dong; Gang Zhao; Jingyu Hang; Junbo Wei; Shixin Ma; Meng Wei; Jinfa Jiang; Haoming Song; Zongjun Liu; Wenquan Zhang; Jingbo Li; Zhigang Lu
Journal:  Cardiology       Date:  2017-07-27       Impact factor: 1.869

6.  Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis.

Authors:  Shichun Chu; Liuhua Hu; Xiaolei Wang; Shiqun Sun; Tuo Zhang; Zhe Sun; Linghong Shen; Shuxuan Jin; Ben He
Journal:  Ren Fail       Date:  2016-11-01       Impact factor: 2.606

7.  Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy.

Authors:  Gulsum Ozkan; Sukru Ulusoy; Asım Orem; Safak Ersoz; Mehmet Alkanat; Fulya Balaban Yucesan; Kubra Kaynar; Sait Al
Journal:  Kidney Blood Press Res       Date:  2012-06-06       Impact factor: 2.687

8.  Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways.

Authors:  Xuezhong Gong; Qian Wang; Xiaochun Tang; Yuerong Wang; Dan Fu; Huayi Lu; Guohua Wang; Svante Norgren
Journal:  Am J Nephrol       Date:  2013-02-26       Impact factor: 3.754

9.  GSPE is superior to NAC in the prevention of contrast-induced nephropathy: might this superiority be related to caspase 1 and calpain 1?

Authors:  Sukru Ulusoy; Gulsum Ozkan; Sevdegül Mungan; Asım Orem; Esin Yulug; Mehmet Alkanat; Fulya Balaban Yucesan
Journal:  Life Sci       Date:  2014-04-12       Impact factor: 5.037

10.  Nephroprotective Effects of N-Acetylcysteine Amide against Contrast-Induced Nephropathy through Upregulating Thioredoxin-1, Inhibiting ASK1/p38MAPK Pathway, and Suppressing Oxidative Stress and Apoptosis in Rats.

Authors:  Xuezhong Gong; Yiru Duan; Junli Zheng; Yiquan Wang; Guohua Wang; Svante Norgren; Tom K Hei
Journal:  Oxid Med Cell Longev       Date:  2016-12-26       Impact factor: 6.543
View more
  3 in total

Review 1.  Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis.

Authors:  Jun Li; Xuezhong Gong
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

2.  Efficacy and Safety of Chuan Huang Fang Combining Reduced Glutathione in Treating Acute Kidney Injury (Grades 1-2) on Chronic Kidney Disease (Stages 2-4): Study Protocol for a Multicenter Randomized Controlled Clinical Trial.

Authors:  Ling Chen; Xuezhong Gong
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-15       Impact factor: 2.629

3.  Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1-2) on chronic kidney disease (stages 2-4): A multicenter randomized controlled clinical trial.

Authors:  Ling Chen; Zi Ye; Danjun Wang; Jianlian Liu; Qian Wang; Chen Wang; Bing Xu; Xuezhong Gong
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.